Combination Leflunomide-Hydroxychloroquine Promising for Sjogren ' s Syndrome Combination Leflunomide-Hydroxychloroquine Promising for Sjogren ' s Syndrome

A combination of two approved drugs, leflunomide and hydroxychloroquine, was safe and elicited a clinical response in a phase-2a trial for Sjogren ' s syndrome.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news